These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26779679)

  • 21. Solution-phase synthesis of nucleobase-substituted analogues of triostin A.
    Lorenz KB; Diederichsen U
    J Org Chem; 2004 May; 69(11):3917-27. PubMed ID: 15153026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
    Xia Y; Duan Q; Zhao BH; Li DF; Hou RB
    Med Chem; 2016; 12(4):338-46. PubMed ID: 26548744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity.
    Galal SA; Khairat SH; Ragab FA; Abdelsamie AS; Ali MM; Soliman SM; Mortier J; Wolber G; El Diwani HI
    Eur J Med Chem; 2014 Oct; 86():122-32. PubMed ID: 25147154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.
    Chu PC; Wu YC; Chen CY; Hung YS; Chang CS
    Future Med Chem; 2021 Jun; 13(12):1057-1072. PubMed ID: 33896195
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways.
    Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN
    Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
    Boovanahalli SK; Jin X; Jin Y; Kim JH; Dat NT; Hong YS; Lee JH; Jung SH; Lee K; Lee JJ
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6305-10. PubMed ID: 17884495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-Phase Synthesis of Triostin A Using a Symmetrical Bis(diphenylmethyl) Linker System.
    Sable GA; Lim D
    J Org Chem; 2015 Aug; 80(15):7486-94. PubMed ID: 26171914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
    Galal SA; Abdelsamie AS; Soliman SM; Mortier J; Wolber G; Ali MM; Tokuda H; Suzuki N; Lida A; Ramadan RA; El Diwani HI
    Eur J Med Chem; 2013 Nov; 69():115-24. PubMed ID: 24013411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
    Lee K; Lee JH; Boovanahalli SK; Jin Y; Lee M; Jin X; Kim JH; Hong YS; Lee JJ
    J Med Chem; 2007 Apr; 50(7):1675-84. PubMed ID: 17328532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
    Na YR; Han KC; Park H; Yang EG
    Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difuran-substituted quinoxalines as a novel class of PI3Kα H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship.
    Zhang N; Yu Z; Yang X; Zhou Y; Tang Q; Hu P; Wang J; Zhang SL; Wang MW; He Y
    Eur J Med Chem; 2018 Sep; 157():37-49. PubMed ID: 30071408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments.
    Martinive P; Defresne F; Quaghebeur E; Daneau G; Crokart N; Grégoire V; Gallez B; Dessy C; Feron O
    FEBS J; 2009 Jan; 276(2):509-18. PubMed ID: 19077164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of sp
    Ueda H; Wipf P; Nakamura H
    Bioorg Med Chem; 2022 Jan; 54():116561. PubMed ID: 34920311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
    Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
    Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
    Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.